Hooks Corwin Dale 4
4 · Clovis Oncology, Inc. · Filed Jun 8, 2018
Insider Transaction Report
Form 4
Hooks Corwin Dale
See Remarks
Transactions
- Tax Payment
Common Stock
2018-06-06$47.70/sh−235$11,210→ 4,684 total - Exercise/Conversion
Restricted Stock Units
2018-06-06−468→ 5,157 total→ Common Stock (468 underlying) - Exercise/Conversion
Common Stock
2018-06-06+468→ 4,919 total
Footnotes (3)
- [F1]Each restricted stock unit represents the right to receive one share of Common Stock.
- [F2]The reporting person filed a Form 4 on June 1, 2018, reporting the conversion of 869 Restricted Stock Units into shares of Common Stock. The amount of securities beneficially owned following this transaction contained a clerical error, and should have been 4,895. The amount of securities beneficially owned after taking into account the second transaction reported on June 1, 2018 remains correct.
- [F3]On March 27, 2017, the reporting person was granted 7,500 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.